A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer

Author： Schelman William   Mohammed Tabraiz   Traynor Anne   Kolesar Jill   Marnocha Rebecca   Eickhoff Jens   Keppen Michael   Alberti Dona   Wilding George   Takebe Naoko   Liu Glenn  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.32, Iss.2, 2014-04, pp. : 295-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment with irinotecan plus cisplatin has a similar survival benefit to etoposide plus cisplatin in patients with extensive-stage small cell lung cancer

By  

Inpharma, Vol. 1, Iss. 1540, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

A Phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer

By Sunpaweravong Patrapim   Magree Lyn   Rabinovitch Rachel   Bunn Paul   Kelly Karen  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 213-221

Springer Publishing Company

Access to resources Recommend Favorite

Is there a Place for Bevacizumab in Patients with Extensive-Stage Small Cell Lung Cancer?

By  

Current Cancer Drug Targets, Vol. 16, Iss. 3, 2016-03 ,pp. : 209-214

Bentham Science Publishers

Access to resources Recommend Favorite

Phase II trial of Sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer

By Sharma Neelesh   Pennell Nathan   Nickolich Myles   Halmos Balazs   Ma Patrick   Mekhail Tarek   Fu Pingfu   Dowlati Afshin  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 362-368

Springer Publishing Company

Access to resources Recommend Favorite

Carboplatin in Combination with Bendamustine in Previously Untreated Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)

By Wolf Köster  

Clinical Drug Investigation, Vol. 24, Iss. 10, 2004-01 ,pp. : 611-618

Adis International

Access to resources Recommend Favorite